Stock HUMAN GENOME SCIENCES
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Human Genome Sciences

Equities

US4449031081

Biotechnology & Medical Research

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Human Genome Sciences
2012 Actelion Ltd : Exclusive: Human Genome rejected Amgen's $7 billion bid in 2010: sources RE
2012 BioMarin Pharmaceutical Inc. : GSK clinches deal to buy Human Genome for $3 billion RE

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 200,202,597 199,790,772 ( 99.79 %) 0 99.79 %

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.12% 42.59B
MODERNA, INC. Stock Moderna, Inc.
+6.77% 40.65B
LONZA GROUP AG Stock Lonza Group AG
+47.98% 40.57B
CELLTRION, INC. Stock Celltrion, Inc.
-11.96% 26.77B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+6.01% 24.81B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-24.92% 18.17B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.63% 11.7B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+27.16% 12.05B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+7.30% 11.1B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. Stock
  4. Company Human Genome Sciences